Clinical Trial Update: Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of brexpiprazole for schizophrenia has completed, potentially informing next regulatory steps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED